| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/22/2010 | WO2010043148A1 2-cyano-3-(substituted) amino-3-phenyl acrylic ester compound, preparing method and use thereof |
| 04/22/2010 | WO2010018113A3 Bi-aryl aminotetralines |
| 04/22/2010 | WO2010003624A3 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/22/2010 | WO2009095773A3 Novel heterocycles |
| 04/22/2010 | WO2009068468A3 Pyridine compounds |
| 04/22/2010 | US20100099884 Method of preparing s-(-)-amlodipine or a salt thereof and an intermediate used therein |
| 04/22/2010 | US20100099710 Src family kinase inhibitors |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099688 Novel phosphodiesterase inhibitors |
| 04/22/2010 | US20100099682 Acetylene derivatives |
| 04/22/2010 | US20100099671 Glucokinase activator |
| 04/22/2010 | CA2740783A1 Sphingosine-1-phosphate receptor antagonists |
| 04/22/2010 | CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/22/2010 | CA2739060A1 Fused-ring derivative and medical application of same |
| 04/22/2010 | CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177512A1 Inhibitor of binding of s1p1 |
| 04/21/2010 | EP2177510A1 Allosteric protein kinase modulators |
| 04/21/2010 | EP2176225A1 Process for the synthesis of diaminopyridine and related compounds |
| 04/21/2010 | EP2176224A2 Process for the synthesis of diaminopyridine and related compounds |
| 04/21/2010 | EP2176223A1 Malonamide derivatives with antithrombotic activity |
| 04/21/2010 | EP2176222A1 Novel herbicides |
| 04/21/2010 | EP2041093B1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 04/21/2010 | EP1610780B1 Cyclic protein tyrosine kinase inhibitors |
| 04/21/2010 | CN101696221A Substituted isoxazoles as fungicides |
| 04/21/2010 | CN101148436B Catalytic synthesis method for pyridine base |
| 04/20/2010 | US7700808 1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 04/20/2010 | US7700794 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds |
| 04/20/2010 | US7700780 Zwitterionic chromophores and macromolecules containing such chromophores |
| 04/20/2010 | US7700658 Administering 3-[[3-(4-chloro-3-ethylphenoxy)phenyl][[3-(1,1,2,2- tetrafluoroethoxy)phenyl]-methyl]amino]- 1,1,1-trifluoro-2-propanol(ylgucpd25); anticholesterol agents to increase the level of high density lipoproteins; atherosclerosis; coronary artery; strokes, cardiovasculardiseases; dyslipidemia |
| 04/20/2010 | US7700632 3-(3-Chloro-biphenyl-4-yloxymethyl)-benzoic acid; antidiabetic; type 2 diabetes, insulin resistance, impaired glucose tolerance, obesity |
| 04/20/2010 | US7700631 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 04/20/2010 | US7700628 Aromatic ether derivatives useful as thrombin inhibitors |
| 04/20/2010 | US7700622 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700522 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 04/20/2010 | US7700201 Multilayer; substrate, electrode, light emitting layer and second electrode; blue color |
| 04/20/2010 | CA2454485C Arthropodicidal anthranilamides |
| 04/20/2010 | CA2433409C Use of mglur5 antagonists for the treatment of pruritic conditions |
| 04/20/2010 | CA2425533C Methods for producing acylphenylalanine |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/15/2010 | WO2010042030A1 Aspartyl protease inhibitors |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010041538A1 Process for producing carbonyloxy compound |
| 04/15/2010 | WO2010041449A1 Anti-allergic agent comprising rxr agonist as active ingredient |
| 04/15/2010 | WO2010040461A1 Method for the preparation of functionalized trihalomethoxy substituted pyridines |
| 04/15/2010 | WO2010040275A1 The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof |
| 04/15/2010 | WO2009152906A3 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
| 04/15/2010 | US20100094018 Catalyst composition, and process for production of cross-coupling compound using the same |
| 04/15/2010 | US20100094017 Using alkylmetal reagents for directed metalation of azaaromatics |
| 04/15/2010 | US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 04/15/2010 | US20100093811 Hiv protease inhibitors |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093733 Amide and urea derivatives for the treatment of metabolic diseases |
| 04/15/2010 | US20100093707 Acid amide derivatives, process for their production and pesticides containing them |
| 04/15/2010 | US20100092427 Pyridinone Diketo Acids: Inhibitors of HIV Replication in Combination Therapy |
| 04/15/2010 | US20100089284 Colorant compound and ink including the colorant compound |
| 04/14/2010 | EP2175512A1 Electrochemical device |
| 04/14/2010 | EP2174931A1 Amide compound and method for controlling plant disease using the same |
| 04/14/2010 | EP2173717A2 Novel glucokinase activators and methods of using same |
| 04/14/2010 | EP2173716A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1641745B1 Propionamide derivatives useful as androgen receptor modulators |
| 04/14/2010 | EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | CN101694867A Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 04/14/2010 | CN101693692A Hybrid ionic liquid hydrate, preparation process and application thereof |
| 04/14/2010 | CN101693687A Method for preparing 2-chloro-N, N-dimethylnicotinamide |
| 04/14/2010 | CN101693211A Transition metal catalyst and method for preparing picoline through adopting catalyst |
| 04/14/2010 | CN101693210A Load type transition metal catalyst and preparation method thereof and method for preparing picoline |
| 04/13/2010 | US7696235 3-{[(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid; post-surgical and post-laser trabeculectomy ocular hypertensive episodes, presurgical adjuncts |
| 04/13/2010 | US7696233 Method for controlling particular insect pests by applying anthranilamide compounds |
| 04/13/2010 | US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 04/13/2010 | US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives |
| 04/13/2010 | US7696208 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are inhibitors of VR1 expression in a cell |
| 04/13/2010 | US7696187 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 04/13/2010 | US7696186 7,9-substituted tetracycline compounds |
| 04/13/2010 | US7696129 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof |
| 04/13/2010 | US7695736 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/13/2010 | US7695728 such as 2-Chloro-3-(2-chloro-6-fluorophenyl)-4-(2-propylamino)-6-([1,2,4]triazol-1-yl)pyridine and 4-chloro-3-(2-chloro-6-fluorophenyl)-2-(2-propylamino)-6-([1,2,4]triazol-1-yl)pyridine |
| 04/13/2010 | CA2379626C Antibacterial composition |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/08/2010 | WO2010039957A1 Tryptophan hydroxylase inhibitors and methods of their use |
| 04/08/2010 | WO2010039238A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | WO2010037688A1 Process for the synthesis of halogenated cyclic compounds |
| 04/08/2010 | WO2010037244A2 Organic compounds |
| 04/08/2010 | WO2010018458A3 Phenol derivatives as hif-alpha modulators |
| 04/08/2010 | WO2010007248A3 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/08/2010 | WO2009018662A9 Renin inhibitors |
| 04/08/2010 | US20100087653 Novel process for the preparation of lercanidipine |
| 04/08/2010 | US20100087494 Fungicide n-(3-phenylpropyl) carboxamide derivatives |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087428 Novel Potassium Channel Blockers |
| 04/08/2010 | CA2739303A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | CA2739263A1 Tryptophan hydroxylase inhibitors and methods of their use |
| 04/08/2010 | CA2735921A1 Process for the synthesis of halogenated cyclic compounds |